DT&CRO (CEO Chaekyu Park) anunció on August 22, 2025 that it has firmó un strategic Memorandum of Understanding (MOU) with RudaCure (CEO Yongho Kim), a empresa biotecnológica specializing in novel drug I+D.
Este acuerdo tiene como objetivo respond to the increasingly sophisticated demand for desarrollo de fármacos in the nacional e internacional pharmaceutical and bio industries, combining the expertise and strengths of both empresas to achieve innovador I+D resultados and competitividad global.
The importance of strategic colaboración to enhance the efficiency of preclinical and ensayo clínicos and accelerate desarrollo de fármacos is growing, and this acuerdo was planned within this industria trend.
A través de esto acuerdo, both empresas will closely collaborate in various areas including: ▲discovery and I+D cooperación for candidato a nuevo fármacos, ▲preclinical and ensayo clínico planning and execution cooperación, and ▲establishment of data-based analysis and investigación apoyo systems.
DT&CRO, as a specialized CRO (Contract Research Organization), possesses accumulated experience in preclinical and ensayo clínico planning and execution, as well as regulatorio response capabilities. RudaCure's innovador desarrollo de fármacos pipeline (including tratamiento de la enfermedad de ojo seco RCI001 and tratamiento del dolor RCI002) and tecnología de plataforma can achieve synergy effects when combined with DT&CRO's clinical desarrollo infrastructure and operational expertise.
CEO Park of DT&CRO declaró, "This MOU with RudaCure se espera que create significant synergies in the preclinical and ensayo clínico fields. Through combining both empresas' technologies and know-how, we will contribute to the nacional biofarmacéutico industria's leap to the next level."
CEO Kim of RudaCure declaró, "Through colaboración with DT&CRO's professional CRO experience and capabilities, we expect to more effectively advance the desarrollo of our new drugs including RCI001 and RCI002. We will work together to achieve tangible investigación resultados."
